Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors

Journal of Breast Cancer ◽

10.4048/jbc.2013.16.1.66 ◽

2013 ◽

Vol 16 (1) ◽

pp. 66 ◽

Author(s):

June Koo Lee ◽

Seock-Ah Im ◽

Daewon Lee ◽

Ji-Yeon Kim ◽

Yoojoo Lim ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Korean Patients ◽

Nonsteroidal Aromatase Inhibitors

Download Full-text

Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study

Clinical Breast Cancer ◽

10.1016/j.clbc.2019.01.015 ◽

2019 ◽

Vol 19 (3) ◽

pp. e452-e458

Author(s):

Yizhao Xie ◽

Yi Li ◽

Yinbin Zhang ◽

Shuqun Zhang ◽

Wei Li ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Retrospective Study ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Nonsteroidal Aromatase Inhibitors

Download Full-text

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

Cancer Investigation ◽

10.1080/07357900701224789 ◽

2007 ◽

Vol 25 (2) ◽

pp. 102-105 ◽

Author(s):

Paolo Carlini ◽

Andrea Michelotti ◽

Gianluigi Ferretti ◽

Sergio Ricci ◽

Diana Giannarelli ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Clinical Evaluation ◽

Hormonal Therapy ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Nonsteroidal Aromatase Inhibitors

Download Full-text

A review of the newer aromatase inhibitors in the management of metastatic breast cancer

Journal of Clinical Pharmacy and Therapeutics ◽

10.1046/j.1365-2710.1998.00145.x ◽

1998 ◽

Vol 23 (2) ◽

pp. 81-90 ◽

Author(s):

Reddy

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast

Download Full-text

531P The role of diuretics in treatment of aromatase inhibitors induced musculoskeletal symptoms in women with non metastatic breast cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00689-x ◽

2016 ◽

Vol 27 ◽

pp. ix172-ix173

Author(s):

A.M. Alhanafy ◽

A.A. Labeeb

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Musculoskeletal Symptoms

Download Full-text

Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors

Oncology ◽

10.1159/000319540 ◽

2010 ◽

Vol 79 (1-2) ◽

pp. 55-61 ◽

Author(s):

Kazuyoshi Motomura ◽

Makoto Ishitobi ◽

Yoshifumi Komoike ◽

Hiroki Koyama ◽

Hideki Nagase ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Estrogen Receptor Alpha ◽

Estrogen Receptor Beta ◽

Metastatic Breast ◽

Progression Free Survival ◽

Free Survival ◽

Download Full-text

53P Aromatase inhibitor and cyclin-dependent kinase 4/6 inhibitor treated HR+/HER2- metastatic breast cancer differ to those treated with Aromatase inhibitors alone on progression

Annals of Oncology ◽

10.1016/j.annonc.2020.10.073 ◽

2020 ◽

Vol 31 ◽

pp. S1263

Author(s):

I. Weerasena ◽

L. Spalding ◽

H. Martin ◽

A. Redfern

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Cyclin Dependent Kinase

Download Full-text

Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors

European Geriatric Medicine ◽

10.1016/j.eurger.2017.06.004 ◽

2017 ◽

Vol 8 (5-6) ◽

pp. 408-412

Author(s):

V. Gunmalm ◽

N.R. Jørgensen ◽

B. Abrahamsen ◽

P. Schwarz

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Bone Loss ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Prevention Of Bone Loss

Download Full-text

Abstract P2-13-03: Prevalence of non-metastatic breast cancer patients treated with aromatase inhibitors in the United States

10.1158/0008-5472.sabcs12-p2-13-03 ◽

2012 ◽

Author(s):

A Liede ◽

RK Hernandez ◽

M Pirolli ◽

J Quigley ◽

D Quach

Keyword(s):

Breast Cancer ◽

United States ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

The United States ◽

Breast Cancer Patients

Download Full-text

Abstract P1-14-04: Clinical Outcomes of Brain Metastasis by Lapatinib (L) and Capecitabine (C) in an Open-Label Expanded Access Study among Korean Patients with HER2 Positive Metastatic Breast Cancer

10.1158/0008-5472.sabcs10-p1-14-04 ◽

2010 ◽

Author(s):

J Ro ◽

S Park ◽

S-B Kim ◽

T-Y Kim ◽

Y-H Im ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Brain Metastasis ◽

Clinical Outcomes ◽

Metastatic Breast ◽

Her2 Positive ◽

Expanded Access ◽

Korean Patients

Download Full-text

Effect of denosumab administration on low bone mineral density (T-score −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer

Journal of Bone and Mineral Metabolism ◽

10.1007/s00774-017-0884-x ◽

2017 ◽

Vol 36 (6) ◽

pp. 716-722 ◽

Author(s):

Katsuhiko Nakatsukasa ◽

Hiroshi Koyama ◽

Yoshimi Ouchi ◽

Kouichi Sakaguchi ◽

Yoshifumi Fujita ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Metastatic Breast Cancer ◽

Bone Mineral ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Japanese Women ◽

Mineral Density ◽

T Score ◽

Low Bone Mineral Density

Download Full-text